Figure 1From: Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment designStudy design. (AWE = adult workplace environment; LDX = lisdexamfetamine dimesylate).Back to article page